Cite

HARVARD Citation

    Akagi, K. et al. (2023). Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer. Lung cancer. pp. 247-253. [Online]. 
  
Back to record